(Q61456218)

1

0 references

Izumi Nagatomo

2

0 references

Shohei Koyama

3

0 references

Daisuke Ito

4

0 references

Satoshi Nojima

5

0 references

Ryota Kurebayashi

6

0 references

Yoshimitsu Nakanishi

7

0 references

Yu Nishijima-Futami

9

0 references

Akio Osa

10

0 references

Takeshi Nakatani

11

0 references

Yasuhiro Kato

12

0 references

Masayuki Nishide

13

0 references

Yoshitomo Hayama

14

0 references

Masayoshi Higashiguchi

15

0 references

Osamu Morimura

16

0 references

Kotaro Miyake

17

0 references

Sujin Kang

18

0 references

Toshiyuki Minami

19

0 references

Haruhiko Hirata

20

0 references

Kota Iwahori

21

0 references

Takayuki Takimoto

22

0 references

Hyota Takamatsu

23

0 references

Yoshito Takeda

24

0 references

Naoki Hosen

25

0 references

Shigenori Hoshino

26

0 references

Yasushi Shintani

27

0 references

Meinoshin Okumura

28

0 references

Toru Kumagai

29

0 references

Kazumi Nishino

30

0 references

Fumio Imamura

31

0 references

Shin-Ichi Nakatsuka

32

0 references

Takashi Kijima

33

0 references

Hiroshi Kida

34

0 references

Atsushi Kumanogoh

describes a project that uses

35

0 references

language of work or name

English

0 references

publication date

20 December 2018

0 references

published in

JCI insight

0 references

volume

3

0 references

issue

24

0 references

ImageQuant

1 reference

Europe PubMed Central

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6338389/fullTextXML

inferred from PubMed Central ID database lookup

cites work

In vitro measurement of chemosensitivity of human small cell lung and gastric cancer cell lines toward cell cycle phase-nonspecific agents under the clinically equivalent area under the curve

1 reference

12 December 2020

Developmental localization of semaphorin H messenger RNA acting as a collapsing factor on sensory axons in the mouse brain.

1 reference

12 December 2020

Semaphorin 7A promotes axon outgrowth through integrins and MAPKs

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor

1 reference

12 December 2020

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

12 December 2020

The gefitinib-sensitizing mutant epidermal growth factor receptor enables transformation of a mouse fibroblast cell line

1 reference

12 December 2020

Semaphorin 7A is a negative regulator of T cell responses.

1 reference

12 December 2020

Non-small cell lung cancer clinical practice guidelines in oncology

1 reference

12 December 2020

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors

1 reference

12 December 2020

Survival of patients with stage I lung cancer detected on CT screening

1 reference

12 December 2020

Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin

1 reference

12 December 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

12 December 2020

Semaphorins and their receptors in immune cell interactions.

1 reference

12 December 2020

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Plexin C1, a receptor for semaphorin 7a, inactivates cofilin and is a potential tumor suppressor for melanoma progression.

1 reference

12 December 2020

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

1 reference

12 December 2020

The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis

1 reference

12 December 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

12 December 2020

Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

1 reference

12 December 2020

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

1 reference

12 December 2020

GOBO: gene expression-based outcome for breast cancer online

1 reference

12 December 2020

Secretome signature of invasive glioblastoma multiforme

1 reference

12 December 2020

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

1 reference

12 December 2020

Intestinal epithelial cell-derived semaphorin 7A negatively regulates development of colitis via αvβ1 integrin

1 reference

12 December 2020

HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer

1 reference

12 December 2020

Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells

1 reference

12 December 2020

Multiplex genome engineering using CRISPR/Cas systems

1 reference

12 December 2020

Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer

1 reference

12 December 2020

Semaphorin7A promotes tumor growth and exerts a pro-angiogenic effect in macrophages of mammary tumor-bearing mice

1 reference

12 December 2020

Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.

1 reference

12 December 2020

Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis

1 reference

12 December 2020

Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.

1 reference

12 December 2020

Semaphorin 7a exerts pleiotropic effects to promote breast tumor progression

1 reference

12 December 2020

miR-17-92/p38α Dysregulation Enhances Wnt Signaling and Selects Lgr6+ Cancer Stem-like Cells during Lung Adenocarcinoma Progression.

1 reference

12 December 2020

Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench

1 reference

12 December 2020

RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis

1 reference

12 December 2020

Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial.

1 reference

12 December 2020